Akers Biosciences Operating Income

Akers Biosciences (AKER) currently reports a operating income of $-14M as of December 2020. That compares with $-7.6M in the prior-year period — down 90.3% year over year. Use the charts on this page to explore Akers Biosciences's operating income history and peer comparisons.

Akers Biosciences's operating income decreased from $-7.6M to $-14M — a 90.3% year-over-year decrease (period ending December 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Akers Biosciences reported $-14M in operating income as of December 2020. That compares with $-7.6M in the prior-year period — down 90.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Akers Biosciences, and consider following AKER for alerts when major investors trade the stock.

Akers Biosciences is classified in the Healthcare sector. On operating income, it currently shows $-14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AKER with unrelated industries.